Home / Coherus Oncology, Inc. (CHRS)

Updated: 2026-03-17 00:37 UTC · Last close: 1.66 (+1.84%)

Coherus Oncology, Inc. (CHRS) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.

The latest close for Coherus Oncology, Inc. (CHRS) came in at 1.66 (+1.84%). The chart is sitting below its 50-day average while still holding above the 200-day average, suggesting shorter-term weakness inside a still positive long-term backdrop. 20-day momentum is positive at +3.11%; price remains inside its roughly 52-week range (0.72–2.51); and ATR14 volatility is elevated at roughly 7.63% of price. RSI(14) stands around 43.9, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Pattern signals currently detected: Double bottom, Cup & handle. Near-term structure is defined by support at 1.58 and resistance at 1.74. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Net income: 168.02M · EPS (basic): 1.43. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

OPEN FULL INTERACTIVE ANALYSIS

Note: This is an algorithmic technical snapshot (not financial advice).

CHRS Chart